Kemnay Advisory Services’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Other funds holding CRNX
FCM
DCM
JT
Kemnay Advisory Services's CRNX Position: Q2 2026 in Review
Kemnay Advisory Services increased its Crinetics Pharmaceuticals (CRNX) stake by 10% in Q2 2026, buying an estimated $3.31K and bringing the position to 938 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #423.
Kemnay Advisory Services first reported a position in CRNX in Q4 2025 and has held it in 3 quarters since. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.
- Kemnay Advisory Services held 938 shares of Crinetics Pharmaceuticals worth $35.1K as of Q2 2026.
- Kemnay Advisory Services bought 89 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $3.31K.
- Crinetics Pharmaceuticals made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #423 holding.
- Kemnay Advisory Services first reported a position in Crinetics Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.
Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.